NCT03934034Not yet recruiting
A Prospective Registry For Patients With Non-Tuberculous Mycobacterial (NTM) Pulmonary Disease in Korea.
Source: ClinicalTrials.gov · Last updated 1 May 2019 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The incidence and prevalence of pulmonary disease due to Non-tuberculous mycobacteria (NTM) is increasing worldwide, and this trend has been confirmed in Korea. Treatment of NTM pulmonary disease is difficult and usually requires more than two years of long-term treatment, and the antibiotic regimens used in treatment vary. Therefore, it is difficult to track the natural history of patients with NTM pulmonary disease, to evaluate the treatment outcome, and to understand the effect of specific medicines on the outcome. Establishing a prospective registry of patients with NTM pulmonary disease is expected to accurately evaluate the progress, treatment modality, and treatment outcome of NTM pulmonary disease.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 22 Apr 2019
- Start date
- Apr 2019
- Primary completion date
- Dec 2029
- Lead sponsor
- Seoul National University Hospital
- NCT number
- NCT03934034
What you commit to
- Study type: Observational
- Planned participants: 1000
- From Apr 2019 to the primary completion date, Dec 2029
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- The causative agent of NTM pulmonary disease is none of M. avium complex, M. abscessus subspecies abscessus, M. abscessus subspecies massiliense, or M. kansasii.
Other
- Patients who have been treated for more than 4 weeks.
Who the study is looking for
- Clinical diagnosis of NTM pulmonary disease.
- The causative agent of NTM pulmonary disease includes: M. avium complex, or M. abscessus subspecies abscessus, or M. abscessus subspecies massiliense, or M. kansasii.
- Patients who starts new treatment (those who have previous history of treatment are eligible)
Age in the registry: 20 years to - · Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.